Table 1

Clinical measures, biomarker prevalence and model definition

MeasureParent cohortMetabolomics subcohort
Controls
n=127
WTC-LI
n=96
Controls
n=15
WTC-LI
n=15
PFT at SPE
 FEV1, % Pred*93 (85–99)72 (66–75)92 (90–98)73 (70–75)
 FVC% Pred*†96 (89–103)79 (72–85)97 (95–100)78 (75–88)
 FEV1/FVC*†76 (73–80)72 (65–77)75 (71–82)71 (64–76)
BMI (kg/m2)
 MMTP entry*†‡28 (26–30)29 (27–31)26 (25–27)29 (26–31)
 SPE*†‡29 (27–31)30 (28–34)26 (24–28)30 (28–31)
 Age on 9/11 (years)41 (37–45)40 (36–45)42 (38–46)39 (37–46)
Exposure N (%)
 Low*13 (10%)21 (22%)1 (7%)4 (27%)
 Intermediate*85 (67%)46 (48%)11 (73%)8 (53%)
 High*29 (23%)29 (30%)3 (20%)3 (20%)
 Duration (months)*3 (1–5)1 (1–4)2 (1–5)3 (1–5)
Lipids (mg/dL)
 Triglycerides164 (98–238)157 (107–243)126 (99–237)133 (110–201)
 HDL§47 (40–55)43 (38–54)48 (45–57)42 (3 5–57)
 LDL¶131 (104–157)131 (108–153)134 (100–144)147 (115–162)
 Heart rate*†‡§ (beats/min)72 (66–76)74 (69–80)66 (64–70)75 (68–79)
BP (mm Hg)
 Systolic†‡§114 (108–124)120 (110–128)110 (100–112)119 (108–129)
 Diastolic‡§70 (70–80)75 (70–81)70 (60– 72)71 (66–80)
  • Values in median (IQR) or N (%) as indicated. Significant by Mann-Whitney U or χ2 between:

  • *127 vs 96.

  • †15 vs 15.

  • ‡ Controls 127 vs 15.

  • §Data available for 14 subcohort WTC-LI cases.

  • ¶Data available for 13 subcohort WTC-LI cases; all comparisons between cases 96 vs 15 were insignificant.

  • BMI, body mass index; BP, blood pressure; FEV 1,%, pred forced expiratory volume in 1 s per cent predicted of normal; FVC %, pred forced vital capacity per cent predicted of normal; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MMTP, medical monitoring and treatment programme; PFT, Pulmonary Function Test; SPE, subspecialty pulmonary examination; WTC-LI, World Trade Center Lung Injury.